Risk factor status and vascular events in patients with symptomatic intracranial stenosis - PubMed (original) (raw)
Comparative Study
Risk factor status and vascular events in patients with symptomatic intracranial stenosis
S Chaturvedi et al. Neurology. 2007.
Abstract
Background: There are limited data on the relationship between control of vascular risk factors and vascular events in patients with symptomatic intracranial arterial stenosis.
Methods: We utilized the Warfarin Aspirin Symptomatic Intracranial Disease study database to analyze vascular and lifestyle risk factors at baseline and averaged over the course of the trial. Cutoff levels defining good control for each factor were prespecified based on national guidelines. Endpoints evaluated included 1) ischemic stroke, myocardial infarction, or vascular death or 2) ischemic stroke alone. Univariate associations were assessed using the log-rank test and multivariable analysis was done using Cox proportional hazards regression.
Results: From baseline until year 2 follow-up, there was not a significant improvement in blood pressure control. During the same period, there were improvements in patients with total cholesterol <200 mg/dL (54.6% to 79.2%, p < 0.001) or low-density lipoprotein <100 mg/dL (28.7% to 55.9%, p < 0.001). Multivariable analysis showed that systolic blood pressure >or=140 mm Hg (HR = 1.79, p = 0.0009, 95% confidence limits 1.27 to 2.52), no alcohol consumption (HR 1.69, 1.21 to 2.39, p = 0.002), and cholesterol >or=200 mg/dL (HR 1.44, 1.004 to 2.07, p = 0.048) were associated with an increased risk of stroke, myocardial infarction, or vascular death. The same risk factors were predictors of ischemic stroke alone in multivariable analysis.
Conclusions: Elevated blood pressure and cholesterol levels in symptomatic patients with intracranial stenosis are associated with an increased risk of stroke and other major vascular events.
Similar articles
- Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M; WASID Study Group. Ovbiagele B, et al. Neurology. 2006 May 9;66(9):1344-9. doi: 10.1212/01.wnl.0000210530.46058.5c. Neurology. 2006. PMID: 16682665 - Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
Ovbiagele B, Lynn MJ, Saver JL, Chimowitz MI; WASID Study Group. Ovbiagele B, et al. Cerebrovasc Dis. 2007;24(2-3):283-8. doi: 10.1159/000105681. Epub 2007 Jul 17. Cerebrovasc Dis. 2007. PMID: 17646693 Clinical Trial. - Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Kasner SE, et al. Circulation. 2006 Jan 31;113(4):555-63. doi: 10.1161/CIRCULATIONAHA.105.578229. Epub 2006 Jan 23. Circulation. 2006. PMID: 16432056 Clinical Trial. - Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO. Qureshi AI, et al. J Neuroimaging. 2009 Oct;19 Suppl 1:1S-10S. doi: 10.1111/j.1552-6569.2009.00414.x. J Neuroimaging. 2009. PMID: 19807850 - Treatment of intracranial atherosclerotic stenosis.
Turan TN, Chimowitz MI. Turan TN, et al. Rev Neurol Dis. 2008 Summer;5(3):117-24. Rev Neurol Dis. 2008. PMID: 18838951 Review.
Cited by
- Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians?
Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, Kim KH, Kim GM, Chung CS, Lee KH, Shin HJ, Ki CS, Jeon P, Kim JS, Hong SC. Bang OY, et al. PLoS One. 2015 Jun 30;10(6):e0130663. doi: 10.1371/journal.pone.0130663. eCollection 2015. PLoS One. 2015. PMID: 26125557 Free PMC article. - Current diagnosis and management of symptomatic intracranial atherosclerotic disease.
Prabhakaran S, Romano JG. Prabhakaran S, et al. Curr Opin Neurol. 2012 Feb;25(1):18-26. doi: 10.1097/WCO.0b013e32834ec16b. Curr Opin Neurol. 2012. PMID: 22143202 Free PMC article. Review. - Endovascular treatment of symptomatic intracranial atherosclerotic disease.
Short JL, Majid A, Hussain SI. Short JL, et al. Front Neurol. 2011 Feb 14;1:160. doi: 10.3389/fneur.2010.00160. eCollection 2011. Front Neurol. 2011. PMID: 21359195 Free PMC article. - How effective is endovascular intracranial revascularization in stroke prevention? Results from Borgess Medical Center Intracranial Revascularization Registry.
Al-Ali F, Cree T, Duan L, Hall S, Jefferson A, Louis S, Major K, Smoker S, Walker S. Al-Ali F, et al. AJNR Am J Neuroradiol. 2011 Aug;32(7):1227-31. doi: 10.3174/ajnr.A2670. Epub 2011 Jul 21. AJNR Am J Neuroradiol. 2011. PMID: 21778241 Free PMC article. - The case for angioplasty in patients with symptomatic intracranial atherosclerosis.
McTaggart RA, Marks MP. McTaggart RA, et al. Front Neurol. 2014 Apr 11;5:36. doi: 10.3389/fneur.2014.00036. eCollection 2014. Front Neurol. 2014. PMID: 24782816 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical